Transglutaminase-2 mediates calcium-regulated crosslinking of the Y-Box 1 (YB-1) translation-regulatory protein in TGFβ1-activated myofibroblasts

Journal of Cellular Biochemistry

Volumn 114, Issue 12, 2013, Pages 2753-2769

  Willis, William L ^a   Hariharan, Seethalakshmi ^a   David, Jason J ^a   Strauch, Arthur Roger ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

MYOFIBROBLAST; RNA BINDING PROTEIN; TRANSGLUTAMINASE 2; TRANSLATIONAL CONTROL; YB 1

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CALCIUM; CYSTAMINE; DANSYLCADAVERINE; DIPHENYLIODONIUM SALT; MESSENGER RNA; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA1; Y BOX BINDING PROTEIN 1;

ARTICLE; CALCIUM CELL LEVEL; COMPETITIVE INHIBITION; CONTROLLED STUDY; CROSS LINKING; HUMAN; HUMAN CELL; LUNG FIBROBLAST; MYOFIBROBLAST; PEROXIDATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PROTEIN INTERACTION; WOUND HEALING;

MYOFIBROBLAST; RNA-BINDING PROTEIN; TRANSGLUTAMINASE 2; TRANSLATIONAL CONTROL; YB-1;

ACTINS; CALCIUM; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; LUNG; MYOFIBROBLASTS; PRIMARY CELL CULTURE; PROTEIN BIOSYNTHESIS; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA1; TRANSGLUTAMINASES; Y-BOX-BINDING PROTEIN 1;

EID: 84885615811     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24624     Document Type: Article

References (90)

1. Allbritton NL, Meyer T, Stryer L,. 1992. Range of messenger action of calcium ion and inositol 1,4,5-trisphosphate. Science 258: 1812-1815.
2. Anderson P,. 2010. Post-transcriptional regulons coordinate the initiation and resolution of inflammation. Nat Rev Immunol 10: 24-35.
3. Aumiller V, Graebsch A, Kremmer E, Niessing D, Forstemann K,. 2012. Drosophila Pur-alpha binds to trinucleotide-repeat containing cellular RNAs and translocates to the early oocyte. RNA Biol 9: 633-643.
4. Badarau E, Collighan RJ, Griffin M,. 2013. Recent advances in the development of tissue transglutaminase (TG2) inhibitors. Amino Acids 44: 119-127.
5. Becker NA, Kelm RJ, Jr., Vrana JA, Getz MJ, Maher LJI,. 2000. Altered sensitivity to single-strand-specific reagents associated with the genomic vascular smooth muscle alpha-actin promoter during myofibroblast differentiation. J Biol Chem 275: 15384-15391.
6. Begg GE, Carrington L, Stokes PH, Matthews JM, Wouters MA, Husain A, Lorand L, Iismaa SE, Graham RM,. 2006. Mechanism of allosteric regulation of transglutaminase 2 by GTP. Proc Natl Acad Sci USA 103: 19683-19688.
7. Berridge MJ,. 2006. Calcium microdomains: Organization and function. Cell Calcium 40: 405-412.
8. Bogatkevich GS, Tourkina E, Abrams CS, Harley RA, Silver RM, Ludwicka-Bradley A,. 2003. Contractile activity and smooth muscle alpha-actin organization in thrombin-induced human lung myofibroblasts. Am J Physiol Lung Cell Mol Physiol 285: L334-L343.
9. Bogatkevich GS, Gustilo E, Oates JC, Feghali-Bostwick C, Harley RA, Silver RM, Ludwicka-Bradley A,. 2005. Distinct PKC isoforms mediate cell survival and DNA synthesis in thrombin-induced myofibroblasts. Am J Physiol Lung Cell Mol Physiol 288: L190-L201.
10. Bondi CD, Manickam N, Lee DY, Block K, Gorin Y, Abboud HE, Barnes JL,. 2010. NAD(P)H oxidase mediates TGF-beta1-induced activation of kidney myofibroblasts. J Am Soc Nephrol 21: 93-102.
11. Bosc LVG, Layne JJ, Nelson MT, Hill-Eubanks DC,. 2005. Nuclear factor of activated T cells and serum response factor cooperatively regulate the activity of an α-actin intronic enhancer. J Biol Chem 280: 26113-26120.
12. Case A, Stein RL,. 2003. Kinetic analysis of the action of tissue transglutaminase on peptide and protein substrates. Biochemistry 42: 9466-9481.
13. Chernov KG, Curmi PA, Hamon L, Mechulam A, Ovchinnikov LP, Pastre D,. 2008. Atomic force microscopy reveals binding of mRNA to microtubules mediated by two major mRNP proteins YB-1 and PABP. FEBS Lett 582: 2875-2881.
14. Chou CY, Streets AJ, Watson PF, Huang L, Verderio EA, Johnson TS,. 2011. A crucial sequence for transglutaminase type 2 extracellular trafficking in renal tubular epithelial cells lies in its N-terminal beta-sandwich domain. J Biol Chem 286: 27825-27835.
15. Cogan JG, Subramanian SV, Polikandriotis JA, Kelm RJ, Jr., Strauch AR,. 2002. Vascular smooth muscle α-actin gene transcription during myofibroblast differentiation requires Sp1/3 protein binding proximal to the MCAT enhancer. J Biol Chem 277: 36433-36442.
16. Coles LS, Bartley MA, Bert A, Hunter J, Polyak S, Diamond P, Vadas MA, Goodall GJ,. 2004. A multi-protein complex containing cold shock domain (Y-box) and polypyrimidine tract binding proteins forms on the vascular endothelial growth factor mRNA. Potential role in mRNA stabilization. Eur J Biochem 271: 648-660.
17. Csencsits K, Wood SC, Lu G, Faust SM, Brigstock D, Eichwald EJ, Orosz CG, Bishop DK,. 2006. Transforming growth factor beta-induced connective tissue growth factor and chronic allograft rejection. Am J Transplant 6: 959-966.
18. Csosz E, Bagossi P, Nagy Z, Dosztanyi Z, Simon I, Fesus L,. 2008. Substrate preference of transglutaminase 2 revealed by logistic regression analysis and intrinsic disorder examination. J Mol Biol 383: 390-402.
19. Dai Y, Dudek N, Li Q, Muma N,. 2011. Phospholipase C, Ca2 +, and calmodulin signaling are required for 5-HT2A receptor-mediated transamidation of Rac1 by transglutaminase. Psychopharmacology 213: 403-412.
20. David JJ, Subramanian SV, Zhang A, Willis WL, Kelm RJ, Leier CV, Strauch AR,. 2012. Y-box binding protein-1 implicated in translational control of fetal myocardial gene expression after cardiac transplant. Exp Biol Med 237: 593-607.
21. Davis J, Burr A, Davis G, Birnbaumer L, Molkentin J,. 2012. A TRPC6-dependent pathway for myofibroblast transdifferentiation and wound healing in vivo. Dev Cell 23: 705-715.
22. Dooley S, Said HM, Gressner AM, Floege J, En-Nia A, Mertens PR,. 2006. Y-box protein-1 is the crucial mediator of antifibrotic interferon-gamma effects. J Biol Chem 281: 1784-1795.
23. Dweck D, Reyes-Alfonso A, Jr., Potter JD,. 2005. Expanding the range of free calcium regulation in biological solutions. Anal Biochem 347: 303-315.
24. Eder P, Molkentin JD,. 2011. TRPC channels as effectors of cardiac hypertrophy. Circ Res 108: 265-272.
25. Elberg G, Chen L, Elberg D, Chan MD, Logan CJ, Turman MA,. 2008. MKL1 mediates TGFbeta1-induced alpha-smooth muscle actin expression in human renal epithelial cells. Am J Physiol Renal Physiol 294: F1116-F1128.
26. Eliseeva IA, Kim ER, Guryanov SG, Ovchinnikov LP, Lyabin DN,. 2011. Y-box-binding protein 1 (YB-1) and its functions. Biochemistry (Mosc) 76: 1402-1433.
27. Evdokimova V, Ovchinnikov LP, Sorensen PH,. 2006. Y-box binding protein 1: Providing a new angle on translational regulation. Cell Cycle 5: 1143-1147.
28. Frangogiannis NG,. 2006. The mechanistic basis of infarct healing. Antioxid Redox Signal 8: 1907-1939.
29. Fraser DJ, Phillips AO, Zhang X, van Roeyen CR, Muehlenberg P, En-Nia A, Mertens PR,. 2008. Y-box protein-1 controls transforming growth factor-beta1 translation in proximal tubular cells. Kidney Int 73: 724-732.
30. Gabbiani G,. 2003. The myofibroblast in wound healing and fibrocontractive diseases. J Pathol 200: 500-503.
31. Griffith B, Pendyala S, Hecker L, Lee PJ, Natarajan V, Thannickal VJ,. 2009. NOX enzymes and pulmonary disease. Antioxid Redox Signal 11: 2505-2516.
32. Grotendorst GR, Rahmanie H, Duncan MR,. 2004. Combinatorial signaling pathways determine fibroblast proliferation and myofibroblast differentiation. FASEB J 18: 469-479.
33. Guilluy C, Rolli-Derkinderen M, Tharaux PL, Melino G, Pacaud P, Loirand G,. 2007. Transglutaminase-dependent RhoA activation and depletion by serotonin in vascular smooth muscle cells. J Biol Chem 282: 2918-2928.
34. Gundemir S, Colak G, Tucholski J, Johnson GVW,. 2012. Transglutaminase 2: A molecular Swiss army knife. Biochim Biophys Acta Mol Cell Res 1823: 406-419.
35. Hanssen L, Frye BC, Ostendorf T, Alidousty C, Djudjaj S, Boor P, Rauen T, Floege J, Mertens PR, Raffetseder U,. 2011. Y-box binding protein-1 mediates profibrotic effects of calcineurin inhibitors in the kidney. J Immunol 187: 298-308.
36. Hecker L, Vittal R, Jones T, Jagirdar R, Luckhardt TR, Horowitz JC, Pennathur S, Martinez FJ, Thannickal VJ,. 2009. NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury. Nat Med 15: 1077-1081.
37. Higashi K, Inagaki Y, Fujimori K, Nakao A, Kaneko H, Nakatsuka I,. 2003. Interferon-gamma interferes with transforming growth factor-beta signaling through direct interaction of YB-1 with Smad3. J Biol Chem 278: 43470-43479.
38. Howell DC, Laurent GJ, Chambers RC,. 2002. Role of thrombin and its major cellular receptor, protease-activated receptor-1, in pulmonary fibrosis. Biochem Soc Trans 30: 211-216.
39. Ientile R, Caccamo D, Griffin M,. 2007. Tissue transglutaminase and the stress response. Amino Acids 33: 385-394.
40. Iismaa SE, Mearns BM, Lorand L, Graham RM,. 2009. Transglutaminases and disease: Lessons from genetically engineered mouse models and inherited disorders. Physiol Rev 89: 991-1023.
41. Jeon JH, Lee HJ, Jang GY, Kim CW, Shim DM, Cho SY, Yeo EJ, Park SC, Kim IG,. 2004. Different inhibition characteristics of intracellular transglutaminase activity by cystamine and cysteamine. Exp Mol Med 36: 576-581.
42. Johnson EM, Kinoshita Y, Weinreb DB, Wortman MJ, Simon R, Khalili K, Winckler B, Gordon J,. 2006. Role of Pur alpha in targeting mRNA to sites of translation in hippocampal neuronal dendrites. J Neurosci Res 83: 929-943.
43. Kanai Y, Dohmae N, Hirokawa N,. 2004. Kinesin transports RNA: Isolation and characterization of an RNA-transporting granule. Neuron 43: 513-525.
44. Keene JD,. 2007. RNA regulons: Coordination of post-transcriptional events. Nat Rev Genet 8: 533-543.
45. Kelm RJ, Jr., Cogan JG, Elder PK, Strauch AR, Getz MJ,. 1999a. Molecular interactions between single-stranded DNA-binding proteins associated with all essential MCAT element in the mouse smooth muscle α-actin promoter. J Biol Chem 274: 14238-14245.
46. Kelm RJ, Jr., Elder PK, Getz MJ,. 1999b. The single-stranded DNA-binding proteins, Purα, Purβ, and MSY1 specifically interact with an exon 3-derived mouse vascular smooth muscle α-actin messenger RNA sequence. J Biol Chem 274: 38268-38275.
47. Keresztessy Z, Csosz E, Harsfalvi J, Csomos K, Gray J, Lightowlers RN, Lakey JH, Balajthy Z, Fesus L,. 2006. Phage display selection of efficient glutamine-donor substrate peptides for transglutaminase 2. Protein Sci 15: 2466-2480.
48. Kiraly R, Csosz E, Kurtan T, Antus S, Szigeti K, Simon-Vecsei Z, Korponay-Szabo IR, Keresztessy Z, Fesus L,. 2009. Functional significance of five noncanonical Ca2+-binding sites of human transglutaminase 2 characterized by site-directed mutagenesis. FEBS J 276: 7083-7096.
49. Knapp AM, Ramsey JE, Wang SX, Godburn KE, Strauch AR, Kelm RJ, Jr., 2006. Nucleoprotein interactions governing cell type-dependent repression of the mouse smooth muscle alpha-actin promoter by single-stranded DNA-binding proteins Pur alpha and Pur beta. J Biol Chem 281: 7907-7918.
50. Kohno K, Izumi H, Uchiumi T, Ashizuka M, Kuwano M,. 2003. The pleiotropic functions of the Y-box-binding protein, YB-1. Bioessays 25: 691-698.
51. Kojima S, Nara K, Rifkin DB,. 1993. Requirement for transglutaminase in the activation of latent transforming growth factor-beta in bovine endothelial cells. J Cell Biol 121: 439-448.
52. Kuo TF, Tatsukawa H, Kojima S,. 2011. New insights into the functions and localization of nuclear transglutaminase 2. FEBS J 278: 4756-4767.
53. Kuroda J, Ago T, Matsushima S, Zhai P, Schneider MD, Sadoshima J,. 2010. NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart. Proc Natl Acad Sci USA 107: 15565-15570.
54. Lin CY, Tsai PH, Kandaswami CC, Chang GD, Cheng CH, Huang CJ, Lee PP, Hwang JJ, Lee MT,. 2011. Role of tissue transglutaminase 2 in the acquisition of a mesenchymal-like phenotype in highly invasive A431 tumor cells. Mol Cancer 10: 87-97.
55. Liu X, Kelm RJ, Jr., Strauch AR,. 2009. Transforming growth factor beta1-mediated activation of the smooth muscle alpha-actin gene in human pulmonary myofibroblasts is inhibited by tumor necrosis factor-alpha via mitogen-activated protein kinase kinase 1-dependent induction of the Egr-1 transcriptional repressor. Mol Biol Cell 20: 2174-2185.
56. Mann AP, Verma A, Sethi G, Manavathi B, Wang H, Fok JY, Kunnumakkara AB, Kumar R, Aggarwal BB, Mehta K,. 2006. Overexpression of tissue transglutaminase leads to constitutive activation of nuclear factor-kappaB in cancer cells: Delineation of a novel pathway. Cancer Res 66: 8788-8795.
57. Masszi A, Speight P, Charbonney E, Lodyga M, Nakano H, Szaszi K, Kapus A,. 2010. Fate-determining mechanisms in epithelial-myofibroblast transition: Major inhibitory role for Smad3. J Cell Biol 188: 383-399.
58. Mehta K, Kumar A, Kim HI,. 2010. Transglutaminase 2: A multi-tasking protein in the complex circuitry of inflammation and cancer. Biochem Pharmacol 80: 1921-1929.
59. Meoli DF, White RJ,. 2009. Thrombin induces fibronectin-specific migration of pulmonary microvascular endothelial cells: Requirement of calcium/calmodulin-dependent protein kinase II. Am J Physiol Lung Cell Mol Physiol 297: L706-L714.
60. Mishra S, Murphy LJ,. 2006. The p53 oncoprotein is a substrate for tissue transglutaminase kinase activity. Biochem Biophys Res Commun 339: 726-730.
61. Murthy SN, Lukas TJ, Jardetzky TS, Lorand L,. 2009. Selectivity in the post-translational, transglutaminase-dependent acylation of lysine residues. Biochemistry 48: 2654-2660.
62. Nekrasov MP, Ivshina MP, Chernov KG, Kovrigina EA, Evdokimova VM, Thomas AA, Hershey JW, Ovchinnikov LP,. 2003. The mRNA-binding protein YB-1 (p50) prevents association of the eukaryotic initiation factor eIF4G with mRNA and inhibits protein synthesis at the initiation stage. J Biol Chem 278: 13936-13943.
63. Nishida M, Onohara N, Sato Y, Suda R, Ogushi M, Tanabe S, Inoue R, Mori Y, Kurose H,. 2007. Gα12/13-mediated up-regulation of TRPC6 negatively regulates endothelin-1-induced cardiac myofibroblast formation and collagen synthesis through nuclear factor of activated T cells activation. J Biol Chem 282: 23117-23128.
64. Norman JT, Lindahl GE, Shakib K, En-Nia A, Yilmaz E, Mertens PR,. 2001. The Y-box binding protein YB-1 suppresses collagen alpha 1(I) gene transcription via an evolutionarily conserved regulatory element in the proximal promoter. J Biol Chem 276: 29880-29890.
65. O'Donnell BV, Tew DG, Jones OT, England PJ,. 1993. Studies on the inhibitory mechanism of iodonium compounds with special reference to neutrophil NADPH oxidase. Biochem J 290: 41-49.
66. Oh K, Park HB, Byoun OJ, Shin DM, Jeong EM, Kim YW, Kim YS, Melino G, Kim IG, Lee DS,. 2011. Epithelial transglutaminase 2 is needed for T cell interleukin-17 production and subsequent pulmonary inflammation and fibrosis in bleomycin-treated mice. J Exp Med 208: 1707-1719.
67. Ohashi S, Koike K, Omori A, Ichinose S, Ohara S, Kobayashi S, Sato TA, Anzai K,. 2002. Identification of mRNA/protein (mRNP) complexes containing Puralpha, mStaufen, fragile X protein, and myosin Va and their association with rough endoplasmic reticulum equipped with a kinesin motor. J Biol Chem 277: 37804-37810.
68. Olsen KC, Sapinoro RE, Kottmann RM, Kulkarni AA, Iismaa SE, Johnson GV, Thatcher TH, Phipps RP, Sime PJ,. 2011. Transglutaminase 2 and its role in pulmonary fibrosis. Am J Respir Crit Care Med 184: 699-707.
69. Onishi H, Kino Y, Morita T, Futai E, Sasagawa N, Ishiura S,. 2008. MBNL1 associates with YB-1 in cytoplasmic stress granules. J Neurosci Res 86: 1994-2002.
70. Park D, Choi SS, Ha KS,. 2010. Transglutaminase 2: A multi-functional protein in multiple subcellular compartments. Amino Acids 39: 619-631.
71. Russell B, Curtis MW, Koshman YE, Samarel AM,. 2010. Mechanical stress-induced sarcomere assembly for cardiac muscle growth in length and width. J Mol Cell Cardiol 48: 817-823.
72. Sabri A, Short J, Guo J, Steinberg SF,. 2002. Protease-activated receptor-1-mediated DNA synthesis in cardiac fibroblast is via epidermal growth factor receptor transactivation: Distinct PAR-1 signaling pathways in cardiac fibroblasts and cardiomyocytes. Circ Res 91: 532-539.
73. Santhanam L, Tuday EC, Webb AK, Dowzicky P, Kim JH, Oh YJ, Sikka G, Kuo M, Halushka MK, Macgregor AM, Dunn J, Gutbrod S, Yin D, Shoukas A, Nyhan D, Flavahan NA, Belkin AM, Berkowitz DE,. 2010. Decreased S-nitrosylation of tissue transglutaminase contributes to age-related increases in vascular stiffness. Circ Res 107: 117-125.
74. Selivanova OM, Guryanov SG, Enin GA, Skabkin MA, Ovchinnikov LP, Serdyuk IN,. 2010. YB-1 is capable of forming extended nanofibrils. Biochemistry (Mosc) 75: 115-120.
75. Skabkin MA, Kiselyova OI, Chernov KG, Sorokin AV, Dubrovin EV, Yaminsky IV, Vasiliev VD, Ovchinnikov LP,. 2004. Structural organization of mRNA complexes with major core mRNP protein YB-1. Nucleic Acids Res 32: 5621-5635.
76. Small EM, Thatcher JE, Sutherland LB, Kinoshita H, Gerard RD, Richardson JA, DiMaio JM, Sadek H, Kuwahara K, Olson EN,. 2010. Myocardin-related transcription factor-A controls myofibroblast activation and fibrosis in response to myocardial infarction. Circ Res 107: 294-304.
77. Snead AN, Insel PA,. 2012. Defining the cellular repertoire of GPCRs identifies a profibrotic role for the most highly expressed receptor, protease-activated receptor 1, in cardiac fibroblasts. FASEB J 26: 4540-4547.
78. Stamnaes J, Fleckenstein B, Sollid LM,. 2008. The propensity for deamidation and transamidation of peptides by transglutaminase 2 is dependent on substrate affinity and reaction conditions. Biochim Biophys Acta 1784: 1804-1811.
79. Stamnaes J, Pinkas DM, Fleckenstein B, Khosla C, Sollid LM,. 2010. Redox regulation of transglutaminase 2 activity. J Biol Chem 285: 25402-25409.
80. Stephens P, Grenard P, Aeschlimann P, Langley M, Blain E, Errington R, Kipling D, Thomas D, Aeschlimann D,. 2004. Crosslinking and G-protein functions of transglutaminase 2 contribute differentially to fibroblast wound healing responses. J Cell Sci 117: 3389-3403.
81. Strauch AR, Hariharan S,. 2013. Dynamic interplay of smooth muscle α-actin gene regulatory proteins reflects the biological complexity of myofibroblast differentiation. Biology (MDPI, Basel) 2: 555-586.
82. Subramanian SV, Kelm RJ, Jr., Polikandriotis JA, Orosz CG, Strauch AR,. 2002. Reprogramming of vascular smooth muscle alpha-actin gene expression as an early indicator of dysfunctional remodeling following heart transplant. Cardiovasc Res 54: 539-548.
83. Subramanian SV, Polikandriotis JA, Kelm RJJ, David JJ, Orosz CG, Strauch AR,. 2004. Induction of vascular smooth muscle alpha-actin gene transcription in transforming growth factor beta1-activated myofibroblasts mediated by dynamic interplay between the Pur repressor proteins and Sp1/Smad coactivators. Mol Biol Cell 15: 4532-4543.
84. Telci D, Collighan RJ, Basaga H, Griffin M,. 2009. Increased TG2 expression can result in induction of transforming growth factor beta1, causing increased synthesis and deposition of matrix proteins, which can be regulated by nitric oxide. J Biol Chem 284: 29547-29558.
85. Willis BC, Borok Z,. 2007. TGF-beta induced EMT: Mechanisms and implications for fibrotic lung disease. Am J Physiol Lung Cell Mol Physiol 293: L525-L534.
86. Wolffe AP,. 1994. Structural and functional properties of the evolutionarily ancient Y-box family of nucleic acid binding proteins. BioEssays 16: 245-251.
87. Yamasaki S, Anderson P,. 2008. Reprogramming mRNA translation during stress. Curr Opin Cell Biol 20: 222-226.
88. Yang WH, Bloch DB,. 2007. Probing the mRNA processing body using protein macroarrays and "autoantigenomics ". RNA 13: 704-712.
89. Zhang A, Liu X, Cogan JG, Fuerst MD, Polikandriotis JA, Kelm RJJ, Strauch AR,. 2005. YB-1 coordinates vascular smooth muscle alpha-actin gene activation by TGFbeta1 and thrombin during differentiation of human pulmonary myofibroblasts. Mol Biol Cell 16: 4931-4940.
90. Zhang A, David JJ, Subramanian SV, Liu X, Fuerst MD, Zhao X, Leier CV, Orosz CG, Kelm RJ, Jr., Strauch AR,. 2008. Serum response factor neutralizes Pur alpha- and Pur beta-mediated repression of the fetal vascular smooth muscle alpha-actin gene in stressed adult cardiomyocytes. Am. J. Physiol Cell Physiol 294: C702-C714.